Yi et al. 2020 (PRJNA602407)
General Details
Title | A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation |
---|---|
Organism | |
Number of Samples | 9 |
Release Date | 2020/01/21 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP243638 |
---|---|
ENA | SRP243638 |
GEO | |
BioProject | PRJNA602407 |
Publication
Title | |
---|---|
Authors | Yi Y,Li Y,Meng Q,Li Q,Li F,Lu B,Shen J,Fazli L,Zhao D,Li C,Jiang W,Wang R,Liu Q,Szczepanski A,Li Q,Qin W,Weiner AB,Lotan TL,Ji Z,Kalantry S,Wang L,Schaeffer EM,Niu H,Dong X,Zhao W,Chen K,Cao Q |
Journal | Nature cell biology |
Publication Date | 2021 Apr |
Abstract | Dysregulated translation is a common feature of cancer. Uncovering its governing factors and underlying mechanism are important for cancer therapy. Here, we report that enhancer of zeste homologue 2 (EZH2), previously known as a transcription repressor and lysine methyltransferase, can directly interact with fibrillarin (FBL) to exert its role in translational regulation. We demonstrate that EZH2 enhances rRNA 2'-O methylation via its direct interaction with FBL. Mechanistically, EZH2 strengthens the FBL-NOP56 interaction and facilitates the assembly of box C/D small nucleolar ribonucleoprotein. Strikingly, EZH2 deficiency impairs the translation process globally and reduces internal ribosome entry site (IRES)-dependent translation initiation in cancer cells. Our findings reveal a previously unrecognized role of EZH2 in cancer-related translational regulation. |
PMC | PMC8162121 |
PMID | 33795875 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR12801029 | PRJNA602407 | Homo sapiens | C4-2 | Ribo-Seq | |||||||||
SRR12801030 | PRJNA602407 | Homo sapiens | C4-2 | Ribo-Seq | |||||||||
SRR12801031 | PRJNA602407 | Homo sapiens | C4-2 | Ribo-Seq | |||||||||
SRR10918472 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
SRR10918473 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
SRR10918474 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
SRR10918475 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
SRR10918476 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
SRR10918477 | PRJNA602407 | Homo sapiens | Human PCa cell line C4-2 | Ribo-Seq | |||||||||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About